AUROMEDICS PHARMA, LLC, — Ertapenem Importer Profile
Pharmaceutical Importer · #3 buyer for Ertapenem · $2.5M import value · 50 shipments · UNITED STATES · DGFT Verified
AUROMEDICS PHARMA, LLC, is the #3 importer of Ertapenem from India with $2.5M in import value and 50 verified shipments. AUROMEDICS PHARMA, LLC, holds a 2.3% market share in Ertapenem imports based in UNITED STATES. The company sources from 1 verified supplier across 9 formulations shipped to 1 country. Overall, AUROMEDICS PHARMA, LLC, imports 4 pharmaceutical products worth $5.0M across 3 therapeutic categories.
AUROMEDICS PHARMA, LLC, — Ertapenem Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ertapenem to AUROMEDICS PHARMA, LLC,?
Verified from 50 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| EUGIA PHARMA SPECIALITIES LIMITED | $2.5M | 50 | 100.0% |
AUROMEDICS PHARMA, LLC, sources Ertapenem from 1 verified Indian supplier based on 50 customs records. The primary supplier is EUGIA PHARMA SPECIALITIES LIMITED accounting for 100.0% of imports.
How Does AUROMEDICS PHARMA, LLC, Compare to Nearest Ertapenem Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | EUGIA US LLC, | UNITED STATES | $5.6M | 112 | $50.0K |
| 1 | EUGIA US LLC | UNITED STATES | $5.5M | 111 | $50.0K |
| 3 | AUROMEDICS PHARMA, LLC, ★ | UNITED STATES | $2.5M | 50 | $50.0K |
| 4 | EUGIA PHARMA (MALTA) LTD, | MALTA | $2.0M | 41 | $50.0K |
| 6 | EUGIA US LLC. | UNITED STATES | $1.3M | 25 | $50.0K |
AUROMEDICS PHARMA, LLC, ranks #3 among 137 Ertapenem importers from India. Average shipment value of $50.0K compared to the market average of $181.0K. The closest competitors by value are EUGIA US LLC, and EUGIA US LLC.
Where Does AUROMEDICS PHARMA, LLC, Import Ertapenem To?
Destination countries from 50 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.5M | 50 | 100.0% |
AUROMEDICS PHARMA, LLC, imports Ertapenem to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.5M.
What Ertapenem Formulations Does AUROMEDICS PHARMA, LLC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| ERTAPENEM FOR INJECTION 1 G/VIAL(Ertapen | $1.2M | 24 |
| ERTAPENEM FOR INJECTION 1 G/VIAL (Ertape | $350.0K | 7 |
| ERTAPENEM FOR INJECTION 1 G/VIAL (ERTAPE | $250.0K | 5 |
| ERTAPENEM FOR INJECTION 1 G/VIAL,(ERTAPE | $250.0K | 5 |
| ERTAPENEM FOR INJECTION 1 G/VIAL, (ERTAP | $150.0K | 3 |
| ERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPEN | $100.0K | 2 |
| ERTAPENEM FOR INJECTION 1G/VIAL(ERTAPENE | $100.0K | 2 |
| ERTAPENEM FOR INJECTION 1G/VIAL(Ertapene | $50.0K | 1 |
| ERTAPENEM FOR INJECTION 1G/VIAL (Ertapen | $50.0K | 1 |
AUROMEDICS PHARMA, LLC, imports 9 distinct Ertapenem formulations from India. The top formulation is ERTAPENEM FOR INJECTION 1 G/VIAL(Ertapen with 24 shipments worth $1.2M.
Regulatory Requirements: Importing Ertapenem into United States
What AUROMEDICS PHARMA, LLC, and other importers must comply with to import Ertapenem from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Ertapenem
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ertapenem from India and How Much Does AUROMEDICS PHARMA, LLC, Import?
India exported $24.8M worth of Ertapenem through 780 shipments from 54 suppliers to 46 countries, serving 137 buyers globally. AUROMEDICS PHARMA, LLC, imports $2.5M of this total, accounting for 2.3% of India's Ertapenem exports with 50 shipments from UNITED STATES. This is verified from 50 customs shipment records covering 9 distinct formulations.
What Is the Average Order Value for AUROMEDICS PHARMA, LLC,'s Ertapenem Imports?
AUROMEDICS PHARMA, LLC,'s average Ertapenem order value is $50.0K per consignment, based on 50 shipments totaling $2.5M. AUROMEDICS PHARMA, LLC, is based in UNITED STATES and ranks #3 among all Ertapenem importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ertapenem to AUROMEDICS PHARMA, LLC,?
AUROMEDICS PHARMA, LLC, sources Ertapenem from 1 verified Indian supplier: EUGIA PHARMA SPECIALITIES LIMITED ($2.5M, 100.0%). This is based on 50 customs records.
How Does AUROMEDICS PHARMA, LLC, Compare to Other Ertapenem Importers?
AUROMEDICS PHARMA, LLC, ranks #3 among 137 Ertapenem importers from India with a 2.3% market share. The top 3 importers are EUGIA US LLC, ($5.6M), EUGIA US LLC ($5.5M), AUROMEDICS PHARMA, LLC, ($2.5M). AUROMEDICS PHARMA, LLC, processed 50 shipments from UNITED STATES.
What Other Advanced Antibiotics Products Does AUROMEDICS PHARMA, LLC, Import?
AUROMEDICS PHARMA, LLC, also imports these advanced antibiotics products. Each links to the detailed product page.
About AUROMEDICS PHARMA, LLC,
AUROMEDICS PHARMA, LLC, imports 4 products worth $5.0M. Beyond Ertapenem, top products include Meropenem, Pemetrexed, Cyclophosphamide. View the complete AUROMEDICS PHARMA, LLC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ertapenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ertapenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AUROMEDICS PHARMA, LLC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AUROMEDICS PHARMA, LLC,'s capped import value divided by total capped export value for Ertapenem across all Indian exporters.
- 5.Verified Records: This page is backed by 50 individual customs records matching AUROMEDICS PHARMA, LLC, importing Ertapenem, covering 9 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 46+ countries, 137+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ertapenem Import Data for AUROMEDICS PHARMA, LLC,
Access order-level details, pricing data, supplier connections, and competitive analysis for AUROMEDICS PHARMA, LLC,'s Ertapenem imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AUROMEDICS PHARMA, LLC,
Full Company Profile →
4 products · $5.0M total trade · 3 categories
AUROMEDICS PHARMA, LLC, × Ertapenem
Verified from customs records
Company Overview
Top Products by AUROMEDICS PHARMA, LLC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AUROMEDICS PHARMA, LLC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ertapenem. For current order-level data, contact TransData Nexus.